January 8, 2024 — Qure.ai, a leading global innovator in medical imaging solutions, has announced its 13th FDA clearance for their AI-enabled solutions. Qure’s chest X-ray based qXR-LN uses artificial intelligence to identify and localize lung nodules, marking another significant milestone for the organization, strengthening its standing as a pioneer in the realm of AI-powered advancements…
January 8, 2024 — GE HealthCare announced it has entered into an agreement to acquire MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide. GE HealthCare expects to leverage MIM…
January 5, 2024 — NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. (Curadh), a global MTR-focused clinical, research and advisory organization, today announced a long-term strategic collaboration to develop and produce novel radiopharmaceuticals for the diagnosis…
January 5, 2024 — Perspective Therapeutics, Inc., announced that it has entered into a patent license agreement with Mayo Clinic for the rights to the PSMA Alpha-PET DoubLET platform technology for the treatment of PSMA-expressing cancers, with an initial focus on prostate. The PSMA Alpha-PET DoubLET platform technology represents a potential leap forward in the field…
January 4, 2024 — Diagnosing cancer today involves using chemical “contrast agents” to improve the accuracy of medical imaging processes such as X-rays as well as computed tomography (CT) and magnetic resonance imaging (MRI) scans. But those agents can be expensive, take more time to use and pose potential health concerns. With a new four-year, $1.125…
January 4, 2024 — Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership (MDOP) designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship. Nova Scotia has a population of over 1 million with an incidence…
January 4, 2024 — Siemens Healthineers announced the Food and Drug Administration clearance of the Magnetom Cima.X 3 Tesla (3T) magnetic resonance imaging whole-body scanner. It possesses the strongest-ever gradient system for a clinically released whole-body MR scanner, making smaller structures in the body visible, and capturing images faster than previous MR scanners. Additionally, the Magnetom…
January 3, 2024 — Incyte Diagnostics announced a significant stride in advancing its pathology services through the implementation of state-of-the-art digital pathology services. Leveraging the innovative technology of Philips IntelliSite Pathology Solution, Incyte Diagnostics has installed two advanced slide scanners at its Spokane Valley laboratory, marking a transformative leap in diagnostic capabilities. The newly installed slide…
January 3, 2024 — The American Roentgen Ray Society (ARRS) announced that Philip Costello, MD, the 118th ARRS President and recently named chair of The Roentgen Fund Board of Trustees, has been awarded the 2024 ARRS Gold Medal. The highest accolade bestowed by North America’s first radiological society, the ARRS Gold Medal has been honoring illustrious service to…